Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials? - Jakobsen - Annals of Lymphoma
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version - NCI
Surgery for Primary Central Nervous System Lymphoma: Is It Time for Reevaluation?
Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Cureus | Primary Thyroid Lymphoma: An Analysis of the National Cancer Database
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Medical Sciences | Free Full-Text | Epidemiology of Non-Hodgkin's Lymphoma
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial | Haematologica
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect
Intercontinental Asian Study Compiles the Relative Incidence of
Non-Hodgkin's Lymphoma in the Elderly (Part 1: Overview and Treatment of Follicular Lymphoma)
Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma - Ehrhardt - 2019 - British Journal of Haematology - Wiley Online Library
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine
Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
Non-Hodgkin lymphoma - The Lancet
Median Survival Time - an overview | ScienceDirect Topics
